Current Open programs
Active programs currently accepting submissions
Agnostic Diagnostics
A diagnostic test to identify any and every pathogen from a single sample.
VACCINES ON DEMAND
Making vaccines where they're needed when they're needed.
Healing Lungs
Advancing technologies that help patients with acute respiratory distress syndrome (ARDS), oxygenate their blood, without further straining ARDS patients' lungs.
Digital MCMs
Empowering people to respond to infectious disease outbreaks through rapidly deployable digital health tools.
Lab at Home
On-demand, at-home detection of biochemical health markers to enable diagnostics and telemedicine services.
ReBooT
Repurposing drugs for biological threats.
Repair
Repurposing and advancing innovations against Rad/Nuc threats.
IMMUNECHIP+
Enhance the usability of 3D human tissue models ("tissue chips") as tools for drug development.
Current Active programs
Active programs, but paused for accepting submissions
ReDIRECT
Repurposing commonly available drugs to rapidly treat conditions caused by exposure to chemical agents.
HI-3
Apply the utility of novel health ecosystems, stakeholder collaborations, and real world to data to maximize clinical impact.
Host-based Diagnostics
Harness a patient's systemic responses to inform on health threats and clinical impact.
Host-directed Therapeutics
Advancing therapies focused on fortifying and restoring balance to the patient's defense mechanisms.
DRIVe Forward
For more information about this program, email: DRIVe_Forward@hhs.gov
Closed programs
Past programs, closed and here for reference
COVID-19 RESPONSE
Rapid and widely available access to COVID-19 testing in the home setting.
ENACT
Interpreting physiological signals for pre- or early symptomatic detection of infection.
BEYOND THE NEEDLE
Develop alternative delivery methods for vaccines and other therapeutics.
DRIVe's IMPACT
We change how the government approaches big health security challenges and threats.
We tackle health security threats by seeking breakthrough devices and technologies.
We model our work on the best practices of the entrepreneurial world.
We use tools and authorities to support new technologies, streamline contracting processes, and launch a network of accelerators.
The team is comprised of scientists and venture entrepreneurs dedicated to identifying threats to health security.